We are live on ! Find out more
AMRI

Albany Molecular Research Inc
AMRI

Delisted

AMRI was delisted on the 31st of August, 2017.

Back to rankings

113 hedge funds and large institutions have $515M invested in Albany Molecular Research Inc in 2014 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 37 increasing their positions, 36 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more call options, than puts

Call options by funds: $6.15M | Put options by funds: $2.52M

95% more capital invested

Capital invested by funds: $264M → $515M (+$251M)

3% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 36

4% less funds holding

Funds holding: 118 → 113 (-5)

18% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 28

Holders
113
Holders Change
-5
Holders Change %
-4.24%
% of All Funds
3.26%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
23
Increased
37
Reduced
36
Closed
28
Calls
$6.15M
Puts
$2.52M
Net Calls
+$3.63M
Net Calls Change
+$3.46M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$13.3M
2
HM
HealthCor Management
New York
+$12.4M
3
DCM
Decade Capital Management
New York
+$8.95M
4
BIM
Bogle Investment Management
Massachusetts
+$7.21M
5
HVC
Healthcare Value Capital
New Jersey
+$6.17M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$15.9M
2
BIT
BlackRock Institutional Trust
California
-$8.91M
3
CS
Credit Suisse
Switzerland
-$2.47M
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$2.42M
5
SFM
Systematic Financial Management
New Jersey
-$1.73M
Name Holding Trade Value Shares
Change 		Change in
Stake
GAM
26
Gotham Asset Management
New York
$3.68M -$436K -31,666 -14%
PPA
27
Parametric Portfolio Associates
Washington
$3.6M +$622K +45,171 +30%
American Century Companies
28
American Century Companies
Missouri
$3.55M -$273K -19,845 -9%
Connor, Clark & Lunn Investment Management (CC&L)
29
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$3.46M +$204K +14,800 +10%
California Public Employees Retirement System
30
California Public Employees Retirement System
California
$3.14M +$1.38K +100 +0%
CBOA
31
Commonwealth Bank of Australia
Australia
$3.05M -$226K -16,400 -9%
AA
32
Ancora Advisors
Ohio
$2.99M -$1.51M -109,700 -41%
HCMT
33
Highland Capital Management (Texas)
Texas
$2.95M +$2.18M +158,541 New
PCM
34
Piermont Capital Management
Missouri
$2.79M +$56K +4,070 +3%
Geode Capital Management
35
Geode Capital Management
Massachusetts
$2.72M -$2.42M -175,902 -55%
GC
36
Guggenheim Capital
Illinois
$2.54M -$785K -57,024 -29%
Two Sigma Investments
37
Two Sigma Investments
New York
$2.46M +$1.45M +105,640 +396%
Bank of New York Mellon
38
Bank of New York Mellon
New York
$2.39M -$1.21M -87,998 -41%
Deutsche Bank
39
Deutsche Bank
Germany
$2.34M +$501K +36,385 +41%
SCM
40
Sterling Capital Management
North Carolina
$2.26M +$1.26M +91,489 +306%
Charles Schwab
41
Charles Schwab
California
$2.25M +$923K +67,020 +124%
AI
42
Analytic Investors
California
$1.92M -$1.12M -81,038 -44%
TCIM
43
TIAA CREF Investment Management
New York
$1.88M -$32.2K -2,340 -2%
Goldman Sachs
44
Goldman Sachs
New York
$1.79M -$1.16M -84,411 -47%
Bessemer Group
45
Bessemer Group
New Jersey
$1.69M – – –
Two Sigma Advisers
46
Two Sigma Advisers
New York
$1.53M +$1.13M +82,200 New
BIM
47
BlackRock Investment Management
Delaware
$1.49M +$10K +726 +0.9%
ACM
48
Atika Capital Management
New York
$1.39M +$1.03M +74,500 New
AQR Capital Management
49
AQR Capital Management
Connecticut
$1.35M +$107K +7,800 +12%
PAM
50
Panagora Asset Management
Massachusetts
$1.33M +$123K +8,902 +14%
1
2
3 4 5

AMRI Hedge Fund Activity: Q1 2014 in Review

113 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q1 2014, worth a combined $515M — up 95% from $264M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of AMRI and 23 opened new positions — a net loss of 5 holders — while 36 trimmed existing stakes and 37 added.

The largest buyer was Millennium Management, adding an estimated $13.3M. The largest seller was Wellington Management Group, cutting an estimated $15.9M.

  • 113 institutional investors held Albany Molecular Research Inc (AMRI) as of Q1 2014, down from 118 in Q4 2013.
  • Funds reported $515M of Albany Molecular Research Inc stock for Q1 2014, up 95% quarter-over-quarter.
  • 23 funds opened new Albany Molecular Research Inc positions in Q1 2014 and 28 closed out, a net change of -5 holders.
  • The largest Albany Molecular Research Inc buyer in Q1 2014 was Millennium Management, an estimated $13.3M added.
  • The largest Albany Molecular Research Inc seller in Q1 2014 was Wellington Management Group, an estimated $15.9M sold.

Based on aggregated 13F filings for Q1 2014.